Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood Sugar
Sponsor: Etta Vita
Summary
This study evaluates the effects of the Etta Vita GLP-1 supplement on appetite, gut health, and blood sugar over a 12-week period. Thirty participants with a BMI of 25 or greater and experiencing at least two of the following issues - food cravings, poor appetite control, irregular bowel movements, bloating, or gut issues - will use the test product daily. The trial is a single-arm, open-label study in which all participants take two capsules of the supplement each morning, no more than 15 minutes before their first meal. Participants complete questionnaires at Baseline, Week 4, Week 8, and Week 12, and attend their local clinic for blood tests (HbA1c, Glucose, and Leptin) at Baseline and Week 12.
Key Details
Gender
All
Age Range
21 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-04-01
Completion Date
2026-08-30
Last Updated
2026-11-18
Healthy Volunteers
Yes
Interventions
Etta Vita GLP-1 Supplement Intervention
All 30 participants receive the Etta Vita GLP-1 supplement (two capsules taken orally each morning, no more than 15 minutes before the first meal of the day) for 12 weeks.
Locations (1)
Citruslabs
Las Vegas, Nevada, United States